Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
- Exemption document 07112025.rarPublication of a document prepared in accordance with Article 1(5)(ba) of Regulation (EU) 2017/1129
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 220 | / | 2025 | ||||||||
| Date of issue: | 2025-11-07 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Publication of a document prepared in accordance with Article 1(5)(ba) of Regulation (EU) 2017/1129 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56. 1. 2 of Act on Public Offering | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, 7 November 2025 – In accordance with the requirements of Article 21(3) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (“Regulation (EU) 2017/1129”), “Sopharma” AD (SFA: Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) has published a document prepared in accordance with Article 1(5)(ba) of Regulation (EU) 2017/1129. The document has been prepared for the purpose of seeking the admission and introduction of 404,359,704 shares in Sopharma AD to trading on the regulated (main) market operated by the Warsaw Stock Exchange. The document is available on the website (https://www.sopharmagroup.com/en/home/investors/prospectuses) of “Sopharma” AD. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Exemption document 07112025.rar Exemption document 07112025.rar | Publication of a document prepared in accordance with Article 1(5)(ba) of Regulation (EU) 2017/1129 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2025-11-07 | Ognian Ivanov Donev | Executive Director | |||
20251107_124628_1312968769_Exemption_document_07112025.rar
